Mainstream

Life biosciences announces research collaboration with singhealth duke nus regenerative medicine institute of singapore (remedis) to expand pipeline of cellular rejuvenation therapies

Life Biosciences Announces Research Collaboration with SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) to Expand Pipeline of Cellular Rejuvenation Therapies

Life Biosciences Announces Research Collaboration with SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) to Expand Pipeline of Cellular Rejuvenation Therapies

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) — –

You might also be interested in reading Soluna Holdings files to sell 4M shares of common stock for holders.

July 22, 2025
In Mainstream